Santen Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report

Santen Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, inflammation and others; OTC ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and others. Santen operates through group companies in Asia, Europe and the US. The company’s R&D activities focus on the development of ophthalmic treatments. Santen is headquartered in Kita-ku, Osaka, Japan.

Scope

  • Detailed information on Santen Pharmaceutical Co Ltd required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Santen Pharmaceutical Co Ltd in the form of a SWOT analysis
  • An in-depth view of the business model of Santen Pharmaceutical Co Ltd including a breakdown and examination of key business segments
  • News about Santen Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Santen Pharmaceutical Co Ltd and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Santen Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Santen Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Taisho Pharmaceutical Holdings Co Ltd

Senju Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Hoya Corp

Daiichi Sankyo Co Ltd

Chugai Pharmaceutical Co Ltd

Astellas Pharma ...

Taisho Pharmaceutical Holdings Co Ltd

Senju Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Hoya Corp

Daiichi Sankyo Co Ltd

Chugai Pharmaceutical Co Ltd

Astellas Pharma Inc

Aqumen Biopharmaceuticals

Alcon Japan Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Santen Pharmaceutical Co Ltd - Key Facts ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Santen Pharmaceutical Co Ltd - Key Facts

Santen Pharmaceutical Co Ltd - Key Employees

Santen Pharmaceutical Co Ltd - Major Products and Services

Santen Pharmaceutical Co Ltd - History

Santen Pharmaceutical Co Ltd - Company Statement

Santen Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Santen Pharmaceutical Co Ltd - Business Description

Business Segment: Medical Devices

Overview

Performance

Business Segment: OTC Pharmaceuticals

Overview

Performance

Business Segment: Others

Performance

Business Segment: Prescription Pharmaceuticals

Overview

Performance

Geographical Segment: Asia

Performance

Geographical Segment: EMEA

Performance

Geographical Segment: Japan

Performance

Geographical Segment: US

Performance

R&D Overview

Santen Pharmaceutical Co Ltd - Corporate Strategy

Santen Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Santen Pharmaceutical Co Ltd - Strengths

Santen Pharmaceutical Co Ltd - Weaknesses

Santen Pharmaceutical Co Ltd - Opportunities

Santen Pharmaceutical Co Ltd - Threats

Santen Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Santen Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 26, 2019: OXB and Santen to develop gene therapy products for retinal disease

Jun 13, 2019: Santen’s commitment to ophthalmology underlined by strong preliminary data and symposia detailing the latest in glaucoma and dry eye disease management at SOE 2019

May 09, 2019: Santen reports fiscal 2018 consolidated performance

Mar 06, 2019: Santen announces selection and launch of its gene therapy drug research and development project for inherited ocular disease treatment for the cyclic innovation for clinical empowerment (CiCLE) program

Mar 06, 2019: Santen announces selection and launch of its photo-crosslinking research and development project for pathologic myopia treatment for the cyclic innovation for clinical empowerment (CiCLE) program

Nov 07, 2018: Santen reports consolidated results for Q2 fiscal 2018

Sep 12, 2018: Santen Pharmaceutical announce personnel changes of representative Director of the Board

Jul 17, 2018: Santen Donates to Japan Flood and Landslide Relief Efforts

Jun 04, 2018: Santen Announces Medium-Term Plan (MTP2020)

May 09, 2018: Santen Reports Fiscal 2017 Consolidated Performance

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Santen Pharmaceutical Co Ltd, Key Facts

Santen Pharmaceutical Co Ltd, Key Employees

Santen Pharmaceutical Co Ltd, Major Products and Services

Santen Pharmaceutical ...

List of Tables

Santen Pharmaceutical Co Ltd, Key Facts

Santen Pharmaceutical Co Ltd, Key Employees

Santen Pharmaceutical Co Ltd, Major Products and Services

Santen Pharmaceutical Co Ltd, History

Santen Pharmaceutical Co Ltd, Other Locations

Santen Pharmaceutical Co Ltd, Subsidiaries

Santen Pharmaceutical Co Ltd, Key Competitors

Santen Pharmaceutical Co Ltd, Ratios based on current share price

Santen Pharmaceutical Co Ltd, Annual Ratios

Santen Pharmaceutical Co Ltd, Annual Ratios (Cont...1)

Santen Pharmaceutical Co Ltd, Annual Ratios (Cont...2)

Santen Pharmaceutical Co Ltd, Interim Ratios

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Santen Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Santen Pharmaceutical Co Ltd, Performance Chart (2015 - 2019)

Santen Pharmaceutical Co Ltd, Ratio Charts

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, ...

List of Figures

Santen Pharmaceutical Co Ltd, Performance Chart (2015 - 2019)

Santen Pharmaceutical Co Ltd, Ratio Charts

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports